Cyclohexanecarboxylic acid, 1-methoxy-4-[4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]-, cis- Chemical Properties

Boiling point:

597.6±50.0 °C(Predicted)

Density 

1.32±0.1 g/cm3(Predicted)

pka

4.23±0.44(Predicted)

InChI

InChI=1S/C17H23N5O3/c1-10-8-13(19-14-9-11(2)21-22-14)20-15(18-10)12-4-6-17(25-3,7-5-12)16(23)24/h8-9,12H,4-7H2,1-3H3,(H,23,24)(H2,18,19,20,21,22)/t12-,17-

InChIKey

QKVACMCXFIAPPC-QASKLWRZSA-N

SMILES

[C@]1(OC)(C(O)=O)CC[C@H](C2=NC(NC3C=C(C)NN=3)=CC(C)=N2)CC1

Cyclohexanecarboxylic acid, 1-methoxy-4-[4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]-, cis- Usage And Synthesis

Uses

Cyclohexanecarboxylic acid, 1-methoxy-4-[4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]-, cis- could be used to synthesise Pralsetinib which is a RET receptor tyrosine kinase inhibitor for the treatment of metastatic RET-driven non-small cell lung cancer.